WHAT DO SPANISH RHEUMATOLOGISTS THINK ABOUT THE EFFICACY OF THE DRUGS USED IN THE MANAGEMENT OF PATIENT WITH RHEUMATOID ARTHRITIS AND POOR PROGNOSIS FACTORS? PROGRESAR-2 PROJECT

Simple item page
dc.conference.dateJUN 12-15, 2019
dc.conference.titleAnnual European Congress of Rheumatology (EULAR)
dc.contributor.authorCarmona, Loreto
dc.contributor.authorNarvaez, J.
dc.contributor.authorCalvo, Jaime
dc.contributor.authorEscudero Contreras, Alejandro
dc.contributor.authorMunoz Fernandez, Santiago
dc.contributor.authorRodriguez-Heredia, Jose M.
dc.contributor.authorRomero-Yuste, Susana
dc.contributor.authorVela Casasempere, Paloma
dc.contributor.authorLuis Baquero, Jose
dc.contributor.authorLujan Valdes, Sara
dc.contributor.authorSancho Jimenez, Juan J.
dc.contributor.authoraffiliation[Carmona, Loreto] InMusc Inst Salud Musculoesquelet, Madrid, Spain
dc.contributor.authoraffiliation[Narvaez, J.] Hosp Univ Bellvitge, Barcelona, Spain
dc.contributor.authoraffiliation[Calvo, Jaime] Hosp Univ Araba, Vitoria, Spain
dc.contributor.authoraffiliation[Escudero Contreras, Alejandro] Hosp Univ Reina Sofia, Cordoba, Spain
dc.contributor.authoraffiliation[Munoz Fernandez, Santiago] Univ Europea, Hosp Univ Infanta Sofia, Madrid, Spain
dc.contributor.authoraffiliation[Rodriguez-Heredia, Jose M.] Hosp Univ Getafe, Madrid, Spain
dc.contributor.authoraffiliation[Romero-Yuste, Susana] Hosp Univ Pontevedra, Pontevedra, Spain
dc.contributor.authoraffiliation[Vela Casasempere, Paloma] Hosp Gen Univ Alicante, Alicante, Spain
dc.contributor.authoraffiliation[Luis Baquero, Jose] Scientia Salus, Madrid, Spain
dc.contributor.authoraffiliation[Lujan Valdes, Sara] Bristol Myers Squibb, Med Dept, Madrid, Spain
dc.contributor.authoraffiliation[Sancho Jimenez, Juan J.] Bristol Myers Squibb, Med Dept, Madrid, Spain
dc.contributor.funderBristol-Myers Squibb
dc.date.accessioned2025-01-07T13:19:50Z
dc.date.available2025-01-07T13:19:50Z
dc.date.issued2019-06-01
dc.identifier.doi10.1136/annrheumdis-2019-eular.6883
dc.identifier.essn1468-2060
dc.identifier.issn0003-4967
dc.identifier.unpaywallURLhttps://ard.bmj.com/content/annrheumdis/78/Suppl_2/1575.2.full.pdf
dc.identifier.urihttps://hdl.handle.net/10668/25431
dc.identifier.wosID472207104569
dc.issue.number2
dc.journal.titleAnnals of the rheumatic diseases
dc.journal.titleabbreviationAnn. rheum. dis.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.page.number1575-1576
dc.publisherBmj publishing group
dc.rights.accessRightsopen access
dc.titleWHAT DO SPANISH RHEUMATOLOGISTS THINK ABOUT THE EFFICACY OF THE DRUGS USED IN THE MANAGEMENT OF PATIENT WITH RHEUMATOID ARTHRITIS AND POOR PROGNOSIS FACTORS? PROGRESAR-2 PROJECT
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number78
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Reina Sofía

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía